Peter Brossart

20.1k citations
291 papers · 12.4k · 1 hit paper · h-index 63

Impact in

  • Immunology top 0.1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Immunotherapy and Immune Responses 98
    • Immune Cell Function and Interaction 39
    • T-cell and B-cell Immunology 29
    • Cancer Immunotherapy and Biomarkers 40
    • CAR-T cell therapy research 30

Peter Brossart

283 papers receiving 12.2k citations

Peter Brossart's Hit Papers

G-quadruplexes: a promising target for cancer therapy 2021 · 372 citations
3720+1+3Years since publication100200300

Peers

Peter Brossart
Comparison fields: 5 of 136
  • Immunology 6.1k
  • Oncology 3.9k
  • Hematology 1.3k
  • Genetics 773
  • Molecular Biology 4.4k
Replace Jonathan Cebon with:
Jonathan Cebon Australia
Ivan D. Horak United States
Eugene Maraskovsky Australia
David Allman United States
Hiroshi Shiku Japan
Larry W. Kwak United States
Anne Durandy France
Thomas Winkler Germany
David F. Stroncek United States
Claudio Tripodo Italy
Peter Brossart relative to Jonathan Cebon Australia Jonathan Cebon's profile →
Citations per field
00.5×1.7×
Jonathan Cebon · 1×
Citations per year

Countries citing papers authored by Peter Brossart

Since Specialization
Citations

This map shows the geographic impact of Peter Brossart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Brossart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Brossart more than expected).

Fields of papers citing papers by Peter Brossart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Brossart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Brossart. The network helps show where Peter Brossart may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Brossart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Brossart Line = papers co-authored together Peter Brossart links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 291 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2000445
2
G-quadruplexes: a promising target for cancer therapy
Hit paper breakdown →
2021372
3 1999262
4 2013260
5 2008227
6
Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL.
1997227
7 2003209
8 1997207
9
Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
1998192
10 2006185
11 2006184
12 2019180
13 2010180
14 2002176
15 1997173
16
The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.
2001171
17 2015169
18 2005163
19 2020158
20 2001156

About Peter Brossart

Peter Brossart is a scholar working on Immunology, Oncology, Molecular Biology, Hematology and Genetics, having authored 291 papers that have together received 12.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (98 papers), Cancer Immunotherapy and Biomarkers (40 papers), Immune Cell Function and Interaction (39 papers), CAR-T cell therapy research (30 papers), T-cell and B-cell Immunology (29 papers), RNA Interference and Gene Delivery (20 papers), vaccines and immunoinformatics approaches (20 papers) and Chronic Myeloid Leukemia Treatments (17 papers). The work is most often cited by research in Immunology (6.1k citations), Oncology (3.9k citations), Hematology (1.3k citations), Genetics (773 citations) and Molecular Biology (4.4k citations). Peter Brossart has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Frank Grünebach, Lothar Kanz, Wolfram Brugger, Annkristin Heine, Alessio Nencioni, Michael J. Bevan, Volker L. Reichardt, Gernot Stuhler, Markus M. Weck and Martin Müller. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Cancer Research, Cancer Immunology Immunotherapy and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact